首页> 中文期刊> 《中国实用医药》 >注射用丁二磺酸腺苷蛋氨酸结合丁二磺酸腺苷蛋氨酸肠溶片治疗肝内胆汁淤积的疗效观察

注射用丁二磺酸腺苷蛋氨酸结合丁二磺酸腺苷蛋氨酸肠溶片治疗肝内胆汁淤积的疗效观察

         

摘要

目的:观察注射用丁二磺酸腺苷蛋氨酸结合丁二磺酸腺苷蛋氨酸肠溶片治疗肝内胆汁淤积的临床效果。方法90例肝内胆汁淤积患者,将其随机分为三组,每组30例。单用注射用丁二磺酸腺苷蛋氨酸为注射组,单用丁二磺酸腺苷蛋氨酸肠溶片为口服组,两药同时应用为结合组,对比并分析各组的治疗效果。结果治疗后所有患者血清总胆红素(TBIL)、结合胆红素(DBIL)、谷丙转氨酶(ALT)和谷草转氨酶(AST)水平均明显下降(P<0.05),结合组下降最为显著,其与注射组及口服组比较,差异有统计学意义(P<0.05);结合组治疗后临床疗效优于注射组和口服组(P<0.05)。结论注射用丁二磺酸腺苷蛋氨酸结合丁二磺酸腺苷蛋氨酸肠溶片治疗肝内胆汁淤积的效果要优于单一用药,值得在临床中广泛应用。%Objective To observe the clinical effect of ademetionine 1,4-butanedisulfonate for injection combined with ademetionine 1,4-butanedisulfonate enteric-coated tablet in the treatment of intrahepatic cholestasis.Methods A total of 90 patients with intrahepatic cholestasis were randomly divided into three groups, with 30 cases in each group. Injection group received single treatment by ademetionine 1,4-butanedisulfonate for injection, oral administration group received ademetionine 1,4-butanedisulfonate enteric-coated tablet for treatment, and combined group received combined treatment by the two drugs. Curative effects of three groups were compared and analyzed.Results After treatment, all patients had decreased levels of total bilirubin (TBIL), direct bilirubin (DBIL), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) (P<0.05). The combined group had the most huge decrease, and its difference with injection group and oral administration group had statistical significance (P<0.05). The combined group also had better clinical effect after treatment than the injection group and the oral administration group (P<0.05).Conclusion Combination of ademetionine 1,4-butanedisulfonate for injection and ademetionine 1,4-butanedisulfonate enteric-coated tablet provides better effect in treating intrahepatic cholestasis than single drug treatment. This method is worthy of widely clinical application.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号